Emil Malak
Emil Malak
is the largest single shareholder of Voip-Pal.com, Inc., a publicly traded company where he serves as a Director and Chief Executive Officer. He has spent the last 16 years overseeing the development of the company’s intellectual property comprised of more than twenty telecommunications patents in the United States and several international patents in Europe, India, Canada and Indonesia. In addition to his work as Voip-Pal’s CEO, Mr. Malak has spent the last 7 years involved with a medical research team of doctors, serving as the chairman of the board of Thorne BioMed Ltd. They are currently conducting cancer research in Germany where they are committed to pursuing a possible reduction to cancer metastasis.
For more information or to contact Emil, please visit his company profile page.
Posts by Emil Malak
A Plea for Clarity and a New Approach on Section 101 in 2020
Note to President Trump: Silicon Valley Pirates Are a Bigger Threat to Intellectual Property Than China
Beyond 101: An Inventor’s Plea for Comprehensive Reform of the U.S. Patent System
President Donald Trump Should Investigate the Corrupt Patent System and Passage of the AIA
